Real-world study of first-line immunotherapy combined with chemoradiotherapy in esophageal squamous cell carcinoma

Real-world study of first-line immunotherapy combined with chemoradiotherapy in esophageal squamous cell carcinoma

Abstract This study aimed to assess the effectiveness, safety, and recurrence patterns of first-line immunotherapy combined with chemoradiotherapy in esophageal squamous cell carcinoma (ESCC) patients. A retrospective analysis of 79 eligible ESCC patients was conducted. Primary outcomes included ove...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaohan Zhao, Chengang Weng, Wuhan Yang, Hongmei Gao, Hesong Wang, Wenzhao Deng, Shuchai Zhu, Wenbin Shen
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Immunotherapy
Radiotherapy
Chemotherapy
Esophageal squamous cell carcinoma
Prognosis
Treatment-related adverse events
Online Access:https://doi.org/10.1038/s41598-025-12250-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-12250-w

Similar Items